Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bavituximab (1 trial)
emtricitabine (emtriva) (2 trials)
tenofovir (viread) (2 trials)
Acquired Immunodeficiency Syndrome (Phase 1)
Hepatitis (Phase 1)
Hepatitis A (Phase 1)
Hepatitis C (Phase 1)
Hepatitis C, Chronic (Phase 1)
Hepatitis, Chronic (Phase 1)
HIV Infections (Phase 1)
Trials (3 total)
Trial APIs (3 total)